Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ranbaxy To Seek Indian Strategic Alliance With Orchid

This article was originally published in PharmAsia News

Executive Summary

Instead of a rumored hostile takeover, Ranbaxy Group appears close to a strategic alliance with Orchid Chemicals & Pharmaceuticals. Solrex Pharmaceuticals, believed to be a Ranbaxy-promoted company, is not expected to increase its recently acquired 14.7 percent share in Orchid, which would have put its investment at the 15 percent threshold requiring it to offer to buy an additional 20 percent of shares. A Ranbaxy-Orchid strategic relationship is seen as beneficial to both since Orchid makes active pharmaceutical ingredients and Ranbaxy already has a strong position in U.S. markets. Neither firm would confirm the plan. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts